-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.
-
Summary
-
Allovir, Inc. quarterly/annual Income Tax Expense (Benefit) history and growth rate from 2021 to 2024.
- Allovir, Inc. Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was $0.000.
- Allovir, Inc. Income Tax Expense (Benefit) for the twelve months ending March 31, 2024 was -$126 K, a 52.5% increase year-over-year.
- Allovir, Inc. annual Income Tax Expense (Benefit) for 2023 was -$126 K, a 52.5% increase from 2022.
- Allovir, Inc. annual Income Tax Expense (Benefit) for 2022 was -$265 K, a 126% decline from 2021.
Income Tax Expense (Benefit), Trailing 12 Months (USD)
Income Tax Expense (Benefit), Quarterly (USD)
Income Tax Expense (Benefit), YoY Quarterly Growth (%)